Rocket Lab Bull-Case Target $293 Sparks Debate
Morgan Stanley elevates Rocket Lab's bull-case to $293, underscoring potential upside even as the stock retreats in a...
This guide clarifies which investors benefit most from target date funds versus index funds, focusing on goals and involvement level.
26,623 articlesMorgan Stanley elevates Rocket Lab's bull-case to $293, underscoring potential upside even as the stock retreats in a...
The NEOS Nasdaq-100 High Income ETF (QQQI) shows a 14% headline yield, but most of that payout is return of capital. ...
May CPI rose 0.5% from April, lifting the annual rate to 4.2%. Energy drove most of the move, while core inflation st...
Oil jumps to its highest price since 2023 as a hot U.S. jobs report spurs inflation worries, sending stocks lower and...
AI infrastructure stocks Bloom Energy, AAOI, and Ciena led a broad market rebound on Monday as investors rotated into...
Over a five-year span ending May 2026, SPHQ beat JQUA by about 5 percentage points despite a sharper pullback in 2022...
As of March 31, 2026, NVIDIA, Apple, and Microsoft account for roughly 43% of VGT, raising questions about true diver...
As AI enthusiasm shakes up the tech market, Microsoft stands out as a potentially steadier megacap. This article brea...
Investors are debating whether removing the weakest members of the S&P 500 improves long-term results. Here's what th...
Oil-led gains and geopolitical risk push the dollar to multi-year highs, with traders haven’t been this bullish on th...
U.S. stocks opened the second half of 2026 with a cautious tone as chip stock profit-taking cooled a brisk first half...
Iran tensions could ripple through travel, housing and markets beyond fuel costs. Analysts warn that higher prices ar...